Federal health officials are reviewing safety data on COVID-19 vaccines in pregnant women and children, and may also reconsider recommendations for older adults.

A new federal vaccine panel appointed by US Health Secretary Robert F Kennedy Jr has recommended tighter restrictions on COVID-19 shots.

Federal health officials are cracking down on telehealth companies’ promotion of unapproved versions of prescription drugs.

Asthma risk in woman has significant associations with body mass index (BMI), body roundness index (BRI), white blood cell count (WBC).

Cell culture-based inactivated influenza vaccine was effective among children and adults during the 2023 to 2024 season, particularly in young children.

One of the largest measles outbreaks in decades is spreading along the Arizona-Utah border, with dozens of confirmed cases among unvaccinated children.

When pediatric asthma definitions incorporate BDR, cases with worse clinical outcomes are identified and overall asthma incidence is underestimated.

The respiratory syncytial virus (RSV) vaccine reduces RSV-associated hospitalization among older adults over 2 seasons.

Long COVID remains globally prevalent following COVID-19 infection, with a significant burden of symptoms lasting 1 to 2 years postinfection.

Four Western states are taking a different approach from the CDC on vaccines for COVID-19, influenza, and RSV.

Dual vs mono antiviral therapy demonstrated superior mortality reduction among high-risk, hospitalized patients with severe influenza.

The FDA has approved updated prescribing information for Airsupra to include the BATURA study in patients with mild asthma.